Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 8

Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life

Authors Skogar Ö, Fall P-A, Hallgren G, Bringer B, Carlsson M, Lennartsson U, Sandbjörk H, Törnhage C-J, Lökk J

Published Date October 2012 Volume 2012:8 Pages 435—442

DOI http://dx.doi.org/10.2147/NDT.S34882

Received 10 June 2012, Accepted 13 August 2012, Published 12 October 2012

Örjan Skogar,1,5 Per-Arne Fall,2 Gunnar Hallgren,3 Birgitta Bringer,2 Miriam Carlsson,1 Ulla Lennartsson,3 Håkan Sandbjörk,3 Carl-Johan Törnhage,4 Johan Lökk5

1Department of Geriatrics, Ryhov Hospital, Jonkoping, Sweden; 2Department of Geriatrics, University Hospital, Linkoping, Sweden; 3Department of Neurology, 4Department of Pediatrics, Skaraborg Hospital, Skövde, Sweden; 5Institution of Neurobiology, Karolinska Institutet, Stockholm, Sweden

Objective: Nonmotor symptoms are common in Parkinson’s disease (PD). Health-related quality of life (HRQoL) is negatively affected by different factors, of which pain and sleep disturbances are important contributors. This study was performed to evaluate and describe subjective experiences of pain, sleeping patterns, and HRQoL in a cohort of PD patients with chronic pain.
Methods: A total of 45 participants with established PD for more than 2 years, and PD-related pain for the preceding three months, were recruited from three sites in Sweden. Data regarding time point for onset, duration and degree of pain parameters, body localization of pain, external influences, and treatments were obtained. HRQoL was evaluated with the Short Form-36® Health Survey, and sleeping patterns were registered with the Parkinson’s disease Sleep Scale, both completed along with a questionnaire.
Results: In one-third of participants, pain preceded the PD diagnosis. Median pain score measured with a visual analog scale was 6.6 and 5.9 (for females and males, respectively) the week before the study. In almost half of the participants, pain was present during all their waking hours. Significantly more females described their pain as troublesome, while more males described their pain as irritating. Feelings of numbness and creeping sensations at night were strongly associated with the maximal visual analog scale scores. Polypharmacy was common; 89% used medication for anxiety/insomnia, and 18% used antidepressants. Only one-third of patients who reported pain relief with analgesics had these prescribed on their drug lists. Sleep was characterized by frequent awakenings. Urinary urgency and restless legs were frequently reported as troublesome. Patients rated HRQoL as significantly worse in all items compared with a healthy reference population matched for age and sex.
Conclusions: Experiences of chronic PD-related pain are complex; there is substantial sleep fragmentation and negative impact on HRQoL.

Keywords: data reporting, pain, Parkinson disease, sleep fragmentation

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other articles by this author:

Diurnal salivary cortisol concentrations in Parkinson’s disease: increased total secretion and morning cortisol concentrations

Skogar Ö, Fall P-A, Hallgren G, Lökk J, Bringer B, Carlsson M, Lennartsson U, Sandbjork H, Törnhage C-J

International Journal of General Medicine 2011, 4:561-569

Published Date: 10 August 2011

Readers of this article also read:

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder

Yamamoto H, Tsuchida H, Nakamae T, Nishida S, Sakai Y, Fujimori A, Narumoto J, Wada Y, Yoshida T, Taga C, Fukui K

Neuropsychiatric Disease and Treatment 2012, 8:579-583

Published Date: 6 December 2012

Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents

Watanabe N, Nishida A, Shimodera S, Inoue K, Oshima N, Sasaki T, Inoue S, Akechi T, Furukawa TA, Okazaki Y

Neuropsychiatric Disease and Treatment 2012, 8:561-569

Published Date: 22 November 2012

Effects of repetitive transcranial magnetic stimulation on clinical, social, and cognitive performance in postpartum depression

Myczkowski ML, Dias AM, Luvisotto T, Arnaut D, Bellini BB, Mansur CG, Rennó J, Tortella G, Ribeiro PL, Marcolin MA

Neuropsychiatric Disease and Treatment 2012, 8:491-500

Published Date: 25 October 2012

New developments in the treatment of partial-onset epilepsy

Besag FM, Patsalos PN

Neuropsychiatric Disease and Treatment 2012, 8:455-464

Published Date: 17 October 2012

Role of aripiprazole in treatment-resistant schizophrenia

Mossaheb N, Kaufmann RM

Neuropsychiatric Disease and Treatment 2012, 8:235-244

Published Date: 29 May 2012

Update on the role of antipsychotics in the treatment of Tourette syndrome

Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J

Neuropsychiatric Disease and Treatment 2012, 8:95-104

Published Date: 12 March 2012

Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition

Perna G, Daccò S, Menotti R, Caldirola D

Neuropsychiatric Disease and Treatment 2011, 7:621-637

Published Date: 19 October 2011